Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin dose study on carotid plaque composition before carotid endarterectomy
ISRCTN16590640Phase 4Completed
- Sponsor
- Università degli Studi dell'Aquila
- Start
- Jul 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rosuvastatin in carotid atheroma (CAS), sponsored by Università degli Studi dell'Aquila. Primary endpoints: MicroRNA expression in atherosclerotic plaques, Plaque RNA or protein levels of metalloproteinases, cholesterol transporters, and other mediators of plaque destabilization and 1 more. Started Jul 2009; status: completed.
02
Drugs
rosuvastatin
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on ISRCTN16590640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16590640.